USP38 and cardiac hypertrophy: Finally, our findings unveiled that USP38 deletion remarkably improves pressure overload-induced cardiac dysfunction, cardiac hypertrophy and myocardial fibrosis, accompanied by reduced the transcriptional level of hypertrophic and fibrotic markers, and vice versa.